Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 7 - Drugs for disorders of the blood or the extracellular fluid
Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065)
09/2003
09/11/2003US20030170231 Remedies and preventives for antiphospholipid antibody syndrome
09/10/2003EP1342730A1 Fusion protein having the enhanced in vivo activity of erythropoietin
09/10/2003EP1341819A2 Peptides and/or proteins and use thereof for the production of a therapeutic and/or prophylactic medicament
09/10/2003EP1341792A2 Amido ether substituted imidazoquinolines
09/10/2003EP1341791A2 Thioether substituted imidazoquinolines
09/10/2003EP1341790A2 Sulfonamido ether substituted imidazoquinolines
09/10/2003EP1341789A2 Aryl ether substituted imidazoquinolines
09/10/2003EP1341784A2 Process for making a thrombin inhibitor
09/10/2003EP1341770A1 Substituted 2-anilino-benzimidazoles and the use thereof as nhe-inhibitors
09/10/2003EP1341767A2 Imidazole and benzimidazole caspase inhibitors and uses thereof
09/10/2003EP1341755A1 Carboxylic acid amide derivatives and their use in the treatment of thromboembolic diseases and tumours
09/10/2003EP1341540A2 Tyrosine kinase inhibitors
09/10/2003EP1341537A2 Pharmaceutically active isoindoline derivatives
09/10/2003EP1341533A1 Synergistic combinations comprising a renin inhibitor for cardiovascular diseases
09/10/2003EP1341476A2 Intrasvascular drug delivery device and use therefor
09/10/2003EP1296948B1 Novel gamma crystalline form of perindopril tert-butylamine salt, preparation method, and pharmaceutical compositions containing same.
09/10/2003EP1253937B1 Use of thrombin derived peptides for the treatment of cardiovascular disorders
09/10/2003EP1194401B1 Diacylhydrazine derivatives
09/10/2003EP1181030B1 Tanacetum parthenium extract
09/10/2003EP1157987B1 S-nitrosothiols as agents for the treatment of circulatory dysfunctions
09/10/2003EP1135139B1 Micronized eplerenone compositions
09/10/2003EP1124572B1 Genes and proteins predictive and therapeutic for renal disease and associated disorders
09/10/2003EP1107813A4 Compositions, systems, and methods for creating in situ, chemically cross-linked, mechanical barriers or covering structures
09/10/2003EP1053029B1 Sterile complex of therapeutic peptide bond to a polysaccharide
09/10/2003EP0948342B1 MEDICAL USES OF scuPA/suPAR COMPLEX
09/10/2003EP0912518B1 Substituted pyridines as selective cyclooxygenase-2 inhibitors
09/10/2003EP0594732B1 Humanized antibody against cd18
09/10/2003CN1441801A Substituted pyrrolopyridinone derivatives useful as phosphodiesterase inhibitors
09/10/2003CN1441799A New thiochromane derivatives and use as thrombin inhibitors
09/10/2003CN1441793A Tocotrienolquinone cyclisation product with anti-hypercholesterol effect
09/10/2003CN1441791A 四唑衍生物 Tetrazole derivative
09/10/2003CN1441787A Modulators of TNF-alpha signaling
09/10/2003CN1441784A Thrombin inhibitors comprising aminoisoquinoline group
09/10/2003CN1441776A Novel aryl, alkenyl and alkynl 4-dedimethylamino tetracycline derivatives
09/10/2003CN1441770A Modified forms of pharmacologically active agents and uses therefor
09/10/2003CN1440981A New-type recombinant tissue factor inhibiting peptide and its prepn and application
09/10/2003CN1440980A Mannosan peptide and its prepn and use
09/10/2003CN1440784A Chinese medicine prepn for treating hemopathy
09/10/2003CN1440769A Chinese herbal medicine for treating hemopathy
09/09/2003US6617359 4-fluoro-N-indan-2-yl benzamide and its use as a pharmaceutical
09/09/2003US6617345 Cyclooxygenase-2 inhibitor is (5-bromo-2-(4-fluorophenyl )-3-(4-(methylsulfonyl)phey)-thiophene), N-(2-(cyclohexyloxy 4-nitrophenyl)-methanesulfonamide), meloxicam, flosulide or cyclic substituted phenyl sulfones or sulfonamides
09/09/2003US6617326 Imidazo-triazine derivatives as ligands for GABA receptors
09/09/2003US6617320 Protease inhibitor; anticoagulants
09/09/2003US6617158 Contacting progenitor cells ex vivo with a cytokine (transforming growth factor); use for treating anemia and other blood disorders
09/09/2003US6617145 Enzymatic protein for use in treatment of thrombosis
09/09/2003US6617134 Dimer of molecular variant of apolipoprotein and processes for the production thereof
09/09/2003US6617100 Solid phase quenching systems
09/09/2003US6616943 Composition comprising Wenguanguo extracts and methods for preparing same
09/09/2003CA2263566C Substituted 6,5-hetero-bicyclic derivatives
09/09/2003CA2142121C Effects of actin filaments on fibrin clot structure and lysis
09/09/2003CA2130174C 4-oxo-2 thioxoimidazolidine derivatives as inhibitors of blood platelet aggregation
09/04/2003WO2003073099A1 Method for diagnosing and monitoring hemostatic dysfunction, severe infection and systematic inflammatory response syndrome
09/04/2003WO2003072780A1 Novel proteins, dnas thereof and use of the same
09/04/2003WO2003072569A1 1,4-disubstituted benzofused cycloalkyl urea compounds useful in treating cytokine mediated diseases
09/04/2003WO2003072557A1 5-phenylthiazole derivatives and use as pi3 kinase inhibitors
09/04/2003WO2003072159A1 N-{5-[4-(4-methyl-piperazino-methyl)­-benzoylamido]-2-methylphenyl}-4-(3-pyridyl)-2-pyrimidine-amine coated stents
09/04/2003WO2003072135A2 Inhibition of inflammatory cytokine production by stimulation of brain muscarinic receptors
09/04/2003WO2003072130A1 Oxygen carrier system, artificial oxygen carrier and reducing agent
09/04/2003WO2003072123A1 Stabilized albumin preparaions
09/04/2003WO2003072116A1 Use of zeolithes for reducing the proportion of lactates and ammonium in human and animal organisms
09/04/2003WO2003072115A1 Ceramic composite materials
09/04/2003WO2003072067A2 Compositions and methods for treating epithelial and retinal tissue diseases
09/04/2003WO2003072035A2 Compositions and methods for the treatment of immune related diseases
09/04/2003WO2003072027A2 Compositions and formulations of 9- nitrocamptothecin polymorphs and methods of use thereof
09/04/2003WO2003072024A2 Methods of treating vascular disease
09/04/2003WO2003051805A3 Substituted phenyl naphthalenes as estrogenic agents
09/04/2003WO2003048120A3 2-aryl pyrrologpyrimidines for a1 and a3 receptors
09/04/2003WO2003045313A3 2-aminoquinoline compounds
09/04/2003WO2003029423A3 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
09/04/2003WO2003025151A3 Circadian control of stem/progenitor cell self-renewal and differentiation and of clock controlled gene expression
09/04/2003WO2002101069A3 Ns4 nucleic acids and polypeptides and methods of use for the treatment of body weight disorders
09/04/2003WO2002087506A8 Method and apparatus for computer modeling diabetes
09/04/2003WO2002079238A3 Protein disulfide isomerase and abc transporter homologous proteins involved in the regulation of energy homeostasis
09/04/2003WO2002064792A3 Molecules for disease detection and treatment
09/04/2003WO2002015892A3 Combination comprising an insulin secretion enhancer and an active ingredient selected from hmg-co-a reductase inhibitors and ace inhibitors
09/04/2003WO2001081622A3 Diagnosis of diseases associated with dna repair
09/04/2003WO2001076451A3 Diagnosis of diseases associated with metabolism
09/04/2003WO2001057261A9 Methods and materials relating to leucine-rich repeat protein-like (lrr protein-like) polypeptides and polynucleotides
09/04/2003WO2000067776A9 Pharmacokinetic and pharmacodynamic modeling of erythropoietin administration
09/04/2003US20030166928 Central nervous system disorders, sleep disorders, eating disorders. sexual disorders, hypotensive agents
09/04/2003US20030166926 Pyrroloazepine derivatives
09/04/2003US20030166911 Hybrid nucleic acids; genetic engineering
09/04/2003US20030166910 Bone morphogenic protein
09/04/2003US20030166859 Controlling cell proliferation, cell differentiation; anticancer agents
09/04/2003US20030166730 Amide derivatives for the treatment of diseases mediated by cytokines
09/04/2003US20030166725 Compounds active at the glucocorticoid receptor
09/04/2003US20030166694 Glycinamides
09/04/2003US20030166685 Acid derivatives of benzene useful as anticoagulants in treating and preventing cardiovascular diseases, as anti-inflammatory agents, and as metastasis inhibitors in treating cancer
09/04/2003US20030166683 N-(4-carbamimidoyl-phenyl)-glycine derivatives
09/04/2003US20030166680 For treating serine protease or dual-serine protease mediated disorders
09/04/2003US20030166671 Amorphous polymorphic forms by grinding or pulverizing; having a distinctive X-ray powder diffraction pattern; anti-tumor and -carcinogenic agents; administered by mouth, intravenous injection and inhalation
09/04/2003US20030166641 Heterocyclic amines such as 1-(3,4-methylenedioxyphenyl)-2-(5 -(3,4-dimethoxyphenyl)pyrimidin-2-yl)- 2,3,4,9-tetrahydro-1H-beta-carboline, used as enzyme inhibitors for prophylaxix of sexual disorders
09/04/2003US20030166630 Amino acid derivatives and their use as medicines
09/04/2003US20030166628 Drugs such as 3-(4-chlorobenzo(b)thiophen-2-yl)-5,6-dihydro-imidazo(2,1-b)thiazole, used as hydroxytryptamine and/or noradrenaline reuptake inhibitors; anxiolytic agents
09/04/2003US20030166613 A macrocyclic diterpene plant extract for treating viral infections; A computer program product for storing the library information of candidate compounds
09/04/2003US20030166579 Thrombin inhibitors comprising an aminoisoquinoline group
09/04/2003US20030166577 Inhibitors for the blood-clotting factor xa
09/04/2003US20030166566 Modified with water-soluble polyoxyethylene glycol
09/04/2003US20030166559 Comprises tumor necrosis factor antagonist activity for treatment of autoimmune conditions
09/04/2003US20030166536 Expression product of DNA encoding human or hybrid human/ mammalian factor VIII, said DNA comprising DNA encoding a modified A2 domain, the DNA having one or more nucleotide substitutions resulting in a coding change at one or more of
1 ... 385 386 387 388 389 390 391 392 393 394 395 396 397 398 399 400 401 402 403 404 405 ... 671